Last week, AMCP Principal Research Scientist Pam Pawloski, PharmD, BCOP, FCCP, presented a project poster at ISPE 2026 in Milan, where she and Cate shared early findings and connected in person with our research collaborators from Italy and Denmark.
The White House made news last month with its blueprint to lower drug prices. But it's also important to note that biosimilars will play a crucial role in fostering competition and lowering costs. Biosimilars are the topic of my latest op-ed, "How to Foster Competition While Cutting Drug Costs," published last month in Morning Consult.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.